The anti-inflammatory function of high-density lipoprotein in type II diabetes: A systematic review

•The ex vivo anti-inflammatory effects of high-density lipoprotein are diminished in type II diabetes.•The in vivo implications of this dysfunction are not well understood.•The mechanism and the direction of causality are unclear.•In-depth research is necessary for understanding the clinical implications.